AG
Artal Group Portfolio holdings
AUM
$930M
1-Year Return
3.57%
This Quarter Return
+1.26%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$4.39B
AUM Growth
-$331M
(-7%)
Cap. Flow
-$46.2M
Cap. Flow
% of AUM
-1.05%
Top 10 Holdings %
Top 10 Hldgs %
49.11%
Holding
164
New
19
Increased
18
Reduced
12
Closed
14
Top Buys
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$38.8M |
| 2 |
OTLY
Oatly Group
OTLY
|
$36.7M |
| 3 |
Tourmaline Bio
TRML
|
$30.3M |
| 4 |
VERV
Verve Therapeutics
VERV
|
$30.1M |
| 5 |
LENZ
LENZ Therapeutics
LENZ
|
$21.5M |
Top Sells
| 1 |
BioNTech
BNTX
|
$98.3M |
| 2 |
Intel
INTC
|
$51.2M |
| 3 |
CCXI
ChemoCentryx, Inc.
CCXI
|
$38.4M |
| 4 |
Broadcom
AVGO
|
$34.8M |
| 5 |
KE Holdings
BEKE
|
$34.2M |
Sector Composition
| 1 | Healthcare | 83.34% |
| 2 | Consumer Discretionary | 12.19% |
| 3 | Consumer Staples | 0.83% |
| 4 | Industrials | 0.53% |
| 5 | Materials | 0.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Bristol-Myers Squibb
BMY
$95.3B
| – | – |
0
| – | – |
|
|
152
BioNTech
BNTX
$27.5B
| – | – |
-900,000
| Closed | -$98.3M |
|
153
Citigroup
C
$175B
| – | – |
0
| – | – |
|
154
Coupang
CPNG
$52.1B
| – | – |
-400,000
| Closed | -$19.7M |
|
155
Ford
F
$46.6B
| – | – |
0
| – | – |
|
156
Freeport-McMoran
FCX
$66.3B
| – | – |
0
| – | – |
|
157
GDS Holdings
GDS
$6.21B
| – | – |
-100,000
| Closed | -$8.11M |
|
158
General Motors
GM
$55.6B
| – | – |
0
| – | – |
|
|
159
Intel
INTC
$107B
| – | – |
-800,000
| Closed | -$51.2M |
|
160
Iovance Biotherapeutics
IOVA
$861M
| – | – |
-400,000
| Closed | -$12.7M |
|
161
KraneShares CSI China Internet ETF
KWEB
$8.53B
| – | – |
0
| – | – |
|
162
Manchester United
MANU
$2.73B
| – | – |
-12,488
| Closed | -$197K |
|
163
Protagonist Therapeutics
PTGX
$3.73B
| – | – |
-75,000
| Closed | -$1.94M |
|
164
Shoals Technologies Group
SHLS
$1.19B
| – | – |
-100,000
| Closed | -$3.48M |
|